Results 151 to 160 of about 283,903 (204)
The Lancet, 2021 Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong provoking risk factors for venous thromboembolism include major surgery and active cancer, but most events are unprovoked.
Khan, Faizan +3 more
core +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Venous Thromboembolism in Pregnancy
Arteriosclerosis, Thrombosis, and Vascular Biology, 2009Low molecular weight heparins (LMWHs) appear to be as safe and effective as unfractionated heparin (UFH) for venous thromboembolic disease (VTED) treatment or prophylaxis during pregnancy. Experience with other parenteral anticoagulant drugs is very limited, and no alternative oral anticoagulants are available to date.
Andrá James
exaly +3 more sources
The Indian Journal of Pediatrics, 1999
Incidence of venous thromboembolism (VTE) in children is rapidly rising. Frequent use of central venous lines (CVLs) in children with a variety of disease processes has contributed to increased incidence of VTE. In addition, increased detection of VTE has been possible due to the availability of sensitive imaging studies such as Color Duplex/Doppler ...
R, Gera, R, Kulkarni
openaire +4 more sources
Incidence of venous thromboembolism (VTE) in children is rapidly rising. Frequent use of central venous lines (CVLs) in children with a variety of disease processes has contributed to increased incidence of VTE. In addition, increased detection of VTE has been possible due to the availability of sensitive imaging studies such as Color Duplex/Doppler ...
R, Gera, R, Kulkarni
openaire +4 more sources
Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, 1998The activation of coagulation in patients with cancer contributes significantly to morbidity and mortality rates and may play a fundamental role in the host response to growing tumours. Patients with cancer are clearly at high risk for the development of venous thromboembolism (VTE), particularly during chemotherapy and surgery.
F R, Rickles, M N, Levine
openaire +2 more sources
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER) [PDF]
Annals of Oncology, 2010 Venous thromboembolism (VTE) prophylaxis remains underutilized, particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized cancer patients before the onset of acute ...
Henri Bounameaux, L Mazzolai
exaly +3 more sources
Treatment of Venous Thromboembolism
Thrombosis and Haemostasis, 1995This review provides meta-analytic data of studies aiming at improved treatment of deep vein thrombosis and pulmonary embolism. The introduction of low molecular weight heparin has considerably ameliorated the initial treatment of deep vein thrombosis, and should now be regarded as the treatment of choice for most patients with deep vein thrombosis ...
ten Cate, J. W. +3 more
openaire +3 more sources
Pregnancy and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2013Pregnancy and the postpartum period are associated with an increased risk of venous thromboembolism (VTE), which complicates 1 to 2 of 1,000 pregnancies and represents a leading cause of mortality during pregnancy in developed countries. Strong evidence for the management of pregnancy-related VTE is missing, mostly because pregnant women have been ...
Barco, Stefano +2 more
openaire +2 more sources
Cancer and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006The evidence of the important two-way clinical correlation between cancer and venous thromboembolism (VTE) dates back to Trousseau's time. Over time it has been established that cancer patients not only exhibit a higher risk of developing VTE when compared with noncancer patients, but also that VTE, especially in its idiopathic presentation, sometimes ...
Piccioli A +4 more
openaire +3 more sources
Prevention of Venous Thromboembolism
Oral and Maxillofacial Surgery Clinics of North America, 2006Venous thromboembolism (VTE) is a preventable cause of significant morbidity and mortality in hospitalized patients, especially in the perioperative period. After identifying the risk factors, it is possible to stratify patients into groups based on their degree of risk for developing VTE.
Divyang, Sorathia +2 more
openaire +2 more sources